摘要
急性呼吸窘迫综合征是临床尤其是ICU内常见的综合征,其发生率和病死率一直居高,早期治疗的前提是早期诊断,早期生物标志物逐步受到青睐,一些新的和原有的生物标志物继续成为研究的焦点,而其中一些如C反应蛋白(CRP)、降钙素原(PCT)已在临床广泛使用。
Especially in the ICU acute respiratory distress syndrome is a common syndrome with high morbidity and mortali- ty, Early diagnosis is important , the early biomarkers be favon'ed gradually, CRP, PCT has been widely used in clinical, some new and original biomarkers still continues to be the focus of the study.
出处
《中国实用内科杂志》
CAS
CSCD
北大核心
2013年第11期840-843,共4页
Chinese Journal of Practical Internal Medicine